Stocktoria
Acumen Pharmaceuticals, Inc. ABOS
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-01
Acumen Pharmaceuticals, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,158,661 | $5.2M | 3.56% |
| MILLENNIUM MANAGEMENT LLC | 659,675 | $1.6M | 1.09% |
| TWO SIGMA INVESTMENTS, LP | 530,812 | $1.3M | 0.88% |
| RENAISSANCE TECHNOLOGIES LLC | 473,946 | $1.1M | 0.78% |
| Point72 Asset Management, L.P. | 67,375 | $159,005 | 0.11% |
| CITADEL ADVISORS LLC | 12,000 | $28,320 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.